Table 1.
Demographic information.
Total n = 178 n (%) |
|
---|---|
Age in years at initiation of atropine | |
Average (range) | 7.8 (2 months–22 years) |
<1 year | 21 (11.8%) |
1–<3 years | 26 (14.6%) |
3–<12 years | 80 (44.9%) |
>12 years | 51 (28.7%) |
Gender | |
Male | 96 (54%) |
Female | 82 (46%) |
Underlying Diagnosis | |
Cerebral Palsy | 98 (55.1%) |
Genetic/syndromic disorder | 35 (19.7%) |
Neuromuscular disease | 17 (9.6%) |
Neurodegenerative condition | 11 (6.2%) |
Brain injury | 5 (2.8%) |
Developmental disorder | 4 (2.2%) |
Multiple congenital anomalies | 4 (2.2%) |
Unknown/other | 4 (2.2%) |